Gremese E - Search Results

1

Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis.

Capuano A, Costanzi S, Peluso G, Zannoni G, Vellone VG, Gremese E, Zoli A, Scott C, Beltrami CA, Romano G, Ferraccioli G. Capuano A, et al. Among authors: gremese e. Arthritis Rheum. 2006 Nov;54(11):3633-9. doi: 10.1002/art.22192. Arthritis Rheum. 2006. PMID: 17075808 Free article. Clinical Trial.

2

Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.

Baraldo M, Ferraccioli G, Pea F, Gremese E, Furlanut M. Baraldo M, et al. Among authors: gremese e. Pharmacol Res. 1999 Dec;40(6):483-6. doi: 10.1006/phrs.1999.0539. Pharmacol Res. 1999. PMID: 10660945

3

Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.

De Vita S, De Marchi G, Sacco S, Gremese E, Fabris M, Ferraccioli G. De Vita S, et al. Among authors: gremese e. Blood Cells Mol Dis. 2001 Jul-Aug;27(4):757-66. doi: 10.1006/bcmd.2001.0446. Blood Cells Mol Dis. 2001. PMID: 11778660 Review.

4

Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.

Ferraccioli GF, Gremese E, Tomietto P, Favret G, Damato R, Di Poi E. Ferraccioli GF, et al. Among authors: gremese e. Rheumatology (Oxford). 2002 Aug;41(8):892-8. doi: 10.1093/rheumatology/41.8.892. Rheumatology (Oxford). 2002. PMID: 12154206 Clinical Trial.

5

Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.

Ferraccioli GF, Assaloni R, Di Poi E, Gremese E, De Marchi G, Fabris M. Ferraccioli GF, et al. Among authors: gremese e. Rheumatology (Oxford). 2002 Oct;41(10):1109-12. doi: 10.1093/rheumatology/41.10.1109. Rheumatology (Oxford). 2002. PMID: 12364628 Clinical Trial.

6

Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association.

Tolusso B, Fabris M, Gremese E, Mosca M, Rovere-Querini P, Ferraccioli GF. Tolusso B, et al. Among authors: gremese e. Ann Rheum Dis. 2003 Aug;62(8):781-2. doi: 10.1136/ard.62.8.781. Ann Rheum Dis. 2003. PMID: 12860739 Free PMC article. No abstract available.

7

Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers.

Ferraccioli GF, Gremese E. Ferraccioli GF, et al. Among authors: gremese e. Ann Rheum Dis. 2004 Jun;63(6):613-5. doi: 10.1136/ard.2003.015586. Epub 2004 Mar 17. Ann Rheum Dis. 2004. PMID: 15028556 Free PMC article. No abstract available.

8

Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.

Ferraccioli G, Gremese E. Ferraccioli G, et al. Among authors: gremese e. Autoimmun Rev. 2004 Jun;3(4):261-6. doi: 10.1016/j.autrev.2003.09.004. Autoimmun Rev. 2004. PMID: 15246021 Review.

9

B cell depletion may lead to normalization of anti-platelet, anti-erythrocyte and antiphospholipid antibodies in systemic lupus erythematosus.

Tomietto P, Gremese E, Tolusso B, Venturini P, De Vita S, Ferraccioli G. Tomietto P, et al. Among authors: gremese e. Thromb Haemost. 2004 Nov;92(5):1150-3. Thromb Haemost. 2004. PMID: 15543346 Review. No abstract available.

10

Benefit/risk of cyclosporine in rheumatoid arthritis.

Gremese E, Ferraccioli GF. Gremese E, et al. Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S101-7. Clin Exp Rheumatol. 2004. PMID: 15552522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters